Antibiotic use in South Korea from 2007 to 2014: A health insurance database-generated time series analysis

PloS One
Juhee ParkDong-Sook Kim

Abstract

Inappropriate antibiotic use significantly contributes to antibiotic-resistance, resulting in reduced antibiotic efficacy and increasing physical burden and cost of disease. The goal of this study was to explore antibiotic usage patterns in South Korea using 2007-2014 health insurance claims data. We used the Health Insurance Review & Assessment Service data, which represents nearly the entire population of South Korea, to discern patterns in antibiotic prescribing practices. The daily dose, as defined by the World Health Organization ([defined daily doses]/1000 inhabitants/day, [DID]), was used as a measure of antibiotic use. Subgroup analyses were performed on the basis of patient characteristics (sex, age, and disease) and provider characteristics (type of medical institution). Antibiotic use in DID increased from 23.5 in 2007 to 27.7 in 2014. The ≤ 6 years old age group showed the highest level of usage at 59.21 DID in 2014, and showed an increasing trend each year. DIDs of beta-lactam antibacterials, penicillins (J01C), other beta-lactam antibacterials (J01D), lincosamides and streptogramins (J01F), quinolone antibacterials (J01M), and other antibacterials (J01X) increased over time. This study provides valuable statistics...Continue Reading

References

May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jae-Hoon SongUNKNOWN Asian Network for Surveillance of Resistant Pathogens Study Group
Apr 25, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H Goossens
Apr 25, 2013·International Journal of Clinical Pharmacology and Therapeutics·Hyun Soon SohnYoung Sook Lee
Jul 16, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Kimberly G BlumenthalAleena Banerji

❮ Previous
Next ❯

Citations

Jun 28, 2018·Pediatrics International : Official Journal of the Japan Pediatric Society·Inmyung SongJu-Young Shin
Mar 12, 2019·Korean journal of pediatrics·Young June Choe, Ju-Young Shin
Sep 28, 2018·The Korean Journal of Internal Medicine·Bongyoung KimHyunjoo Pai
Jul 18, 2018·Emerging Infectious Diseases·Joon Kee LeeEun Hwa Choi
Aug 4, 2020·Journal of Korean Medical Science·Bongyoung KimUNKNOWN Health Insurance Review & Assessment Service
Jun 23, 2020·Emerging Infectious Diseases·Yu-Chin ChenTu-Hsuan Chang
May 22, 2019·Helicobacter·Jeong Hoon LeeUNKNOWN Upper Gastrointestinal Research
Sep 10, 2020·Risk Management and Healthcare Policy·Hyungtae Kim, Hae Sun Suh
Jun 3, 2021·Pharmaceutics·Seung-Hyun JeongYong-Bok Lee

❮ Previous
Next ❯

Software Mentioned

SAS
STATA SE

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.